| A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study HM Keys, JA Roberts, VL Brunetto, RJ Zaino, NM Spirtos, JD Bloss, ... Gynecologic oncology 92 (3), 744-751, 2004 | 1992 | 2004 |
| Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study ME Randall, VL Filiaci, H Muss, NM Spirtos, RS Mannel, J Fowler, ... Journal of Clinical Oncology 24 (1), 36-44, 2006 | 1102 | 2006 |
| Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study GF Fleming, VL Brunetto, D Cella, KY Look, GC Reid, AR Munkarah, ... Journal of Clinical Oncology 22 (11), 2159-2166, 2004 | 753 | 2004 |
| Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer D Matei, V Filiaci, ME Randall, D Mutch, MM Steinhoff, PA DiSilvestro, ... New England Journal of Medicine 380 (24), 2317-2326, 2019 | 374 | 2019 |
| A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study G Sutton, VL Brunetto, L Kilgore, JT Soper, R McGehee, G Olt, SS Lentz, ... Gynecologic oncology 79 (2), 147-153, 2000 | 327 | 2000 |
| Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study HD Homesley, V Filiaci, M Markman, P Bitterman, L Eaton, LC Kilgore, ... Journal of Clinical Oncology 25 (5), 526-531, 2007 | 325 | 2007 |
| Randomized phase Ill noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study D Miller, V Filiaci, G Fleming, R Mannel, D Cohn, T Matsumoto, K Tewari, ... Gynecologic oncology 125 (3), 771-771, 2012 | 310* | 2012 |
| Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study JV Fiorica, VL Brunetto, P Hanjani, SS Lentz, R Mannel, W Andersen Gynecologic oncology 92 (1), 10-14, 2004 | 306 | 2004 |
| Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/carboplatin in high-intermediate and high-risk early-stage endometrial cancer ME Randall, V Filiaci, DS McMeekin, V Von Gruenigen, H Huang, ... Journal of Clinical Oncology 37 (21), 1810, 2019 | 292 | 2019 |
| A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a … HD Homesley, V Filiaci, SK Gibbons, HJ Long, D Cella, NM Spirtos, ... Gynecologic oncology 112 (3), 543-552, 2009 | 280 | 2009 |
| Phase III randomized trial of doxorubicin+ cisplatin versus doxorubicin+ 24-h paclitaxel+ filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study GF Fleming, VL Filiaci, RC Bentley, T Herzog, J Sorosky, L Vaccarello, ... Annals of Oncology 15 (8), 1173-1178, 2004 | 271 | 2004 |
| A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study PG Rose, VL Brunetto, L VanLe, J Bell, JL Walker, RB Lee Gynecologic oncology 78 (2), 212-216, 2000 | 254 | 2000 |
| Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study CW Whitney, VL Brunetto, RJ Zaino, SS Lentz, J Sorosky, DK Armstrong, ... Gynecologic oncology 92 (1), 4-9, 2004 | 240 | 2004 |
| Carboplatin and paclitaxel for advanced endometrial cancer: final overall survival and adverse event analysis of a phase III trial (NRG Oncology/GOG0209) DS Miller, VL Filiaci, RS Mannel, DE Cohn, T Matsumoto, KS Tewari, ... Journal of Clinical Oncology 38 (33), 3841, 2020 | 201 | 2020 |
| Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study M Singh, RJ Zaino, VJ Filiaci, KK Leslie Gynecologic oncology 106 (2), 325-333, 2007 | 198 | 2007 |
| An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study KY Look, VL Brunetto, DL Clarke-Pearson, HE Averette, FJ Major, ... Gynecologic oncology 63 (3), 304-311, 1996 | 190 | 1996 |
| Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study MA Powell, VL Filiaci, PG Rose, RS Mannel, P Hanjani, K DeGeest, ... Journal of clinical oncology 28 (16), 2727, 2010 | 188 | 2010 |
| An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study TA Grushko, VL Filiaci, AJ Mundt, K Ridderstråle, OI Olopade, GF Fleming Gynecologic oncology 108 (1), 3-9, 2008 | 187 | 2008 |
| Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study RJ Osborne, V Filiaci, JC Schink, RS Mannel, A Alvarez Secord, JL Kelley, ... Journal of Clinical Oncology 29 (7), 825-831, 2011 | 181 | 2011 |
| The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology … DS McMeekin, VL Filiaci, JT Thigpen, HH Gallion, GF Fleming, ... Gynecologic oncology 106 (1), 16-22, 2007 | 167 | 2007 |
